A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication.
Dengue virus (DENV) infection causes the most prevalent arthropod-borne viral disease worldwide. Approved vaccines are not available, and targets suitable for the development of antiviral drugs are lacking. One possible drug target is nonstructural protein 4B (NS4B), because it is absolutely required for virus replication; however, its exact role in the DENV replication cycle is largely unknown. With the aim of mapping NS4B determinants critical for DENV replication, we performed a reverse genetic screening of 33 NS4B mutants in the context of an infectious DENV genome. While the majority of these mutations were lethal, for several of them, we were able to select for second-site pseudoreversions, most often residing in NS4B and restoring replication competence. To identify all viral NS4B interaction partners, we engineered a fully viable DENV genome encoding an affinity-tagged NS4B. Mass spectrometry-based analysis of the NS4B complex isolated from infected cells identified the NS3 protease/helicase as a major interaction partner of NS4B. By combining the genetic complementation map of NS4B with a replication-independent expression system, we identified the NS4B cytosolic loop-more precisely, amino acid residue Q134-as a critical determinant for NS4B-NS3 interaction. An alanine substitution at this site completely abrogated the interaction and DENV RNA replication, and both were restored by pseudoreversions A69S and A137V. This strict correlation between the degree of NS4B-NS3 interaction and DENV replication provides strong evidence that this viral protein complex plays a pivotal role during the DENV replication cycle, hence representing a promising target for novel antiviral strategies.


OBJECTIVE
With no approved therapy or vaccine against dengue virus infection, the viral nonstructural protein 4B (NS4B) represents a possible drug target, because it is indispensable for virus replication. However, little is known about its precise structure and function. Here, we established the first comprehensive genetic interaction map of NS4B, identifying amino acid residues that are essential for virus replication, as well as second-site mutations compensating for their defects. Additionally, we determined the NS4B viral interactome in infected cells and identified the NS3 protease/helicase as a major interaction partner of NS4B. We mapped residues in the cytosolic loop of NS4B as critical determinants for interaction with NS3, as well as RNA replication. The strong correlation between NS3-NS4B interaction and RNA replication provides strong evidence that this complex plays a pivotal role in the viral replication cycle, hence representing a promising antiviral drug target.
Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.
Laurent
L
Chatel-Chaix
Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.
Wolfgang
W
Fischl
Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.
Pietro
P
Scaturro
Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.
Mirko
M
Cortese
Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.
Stephanie
S
Kallis
Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.
Marie
M
Bartenschlager
Computational Genome Biology, German Cancer Research Center, Heidelberg, Germany.
Bernd
B
Fischer
Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany ralf_bartenschlager@med.uni-heidelberg.de.
Ralf
R
Bartenschlager
D019943:Amino Acid Substitution; D002460:Cell Line; D004252:DNA Mutational Analysis; D003716:Dengue Virus / Q000235:genetics / Q000502:physiology*; D005816:Genetic Complementation Test; D022781:Hepatocytes / Q000821:virology; D006801:Humans; D013058:Mass Spectrometry; D050296:Microbial Viability; D050505:Mutant Proteins / Q000235:genetics / Q000378:metabolism; D011485:Protein Binding; D025941:Protein Interaction Mapping; D020365:RNA Helicases / Q000378:metabolism; D059386:Reverse Genetics; D012697:Serine Endopeptidases / Q000378:metabolism; D013489:Suppression, Genetic; D017361:Viral Nonstructural Proteins / Q000235:genetics / Q000378:metabolism*; D014779:Virus Replication; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases
D050505:Mutant Proteins; D020365:RNA Helicases; D012697:Serine Endopeptidases; D017361:Viral Nonstructural Proteins; C060028:NS3 protein, flavivirus; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases; C080107:NS4B protein, flavivirus